Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dolby Laboratories, Inc.DLB · Entity 2518 | Director | April 01, 2026 | April 03, 2026 |
| Xometry, Inc.XMTR · Entity 1915 | Director | August 19, 2026 | August 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dolby Laboratories, Inc.
Report date April 01, 2026 · Filed April 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 12,541 |
Reported balance
After 2026-04-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-04-01 · Sale · Disposed 1,000 · Balance 12,541 F1: Shares held following the reported transaction included 3,908 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held following the reported transaction included 3,908 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
Xometry, Inc.
Report date August 19, 2026 · Filed August 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 15,136 |
Ending reported balance
After 2026-08-19 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-08-19 · Exercise / conversion · Acquired 5,000 · Balance 20,136 F1: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Row 2 · 2026-08-19 · Sale · Disposed 2,540 · Balance 17,596 F1: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.155 to $84.125, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Row 3 · 2026-08-19 · Sale · Disposed 1,692 · Balance 15,904 F1: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.17 to $85.17, inclusive. Row 4 · 2026-08-19 · Sale · Disposed 768 · Balance 15,136 F1: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.22 to $86.07, inclusive. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.32 · Expires 2031-02-24 | Direct | 41,650 |
Reported balance
After 2026-08-19 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-08-19 · Exercise / conversion · Acquired 5,000 · Balance 41,650 F1: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F5: Fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.155 to $84.125, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.17 to $85.17, inclusive.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.22 to $86.07, inclusive.
F5: Fully vested.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
McAfee Corp.
Report date March 01, 2022 · Filed March 03, 2022
Section 16 reporting ended · disclosed 2022-03-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-03-01 transaction · row 1
1 source rowRow 1 · 2022-03-01 · Disposition to issuer · Disposed 6,878 · Balance 0 F1: Includes restricted stock units ("RSUs") that represent the Reporting Person's right to receive shares of Class A common stock of the Issuer. The RSUs were cancelled pursuant to that certain Merger Agreement, dated November 5, 2021, between the Issuer, Condor BidCo, Inc. and Condor Merger Sub, Inc., in exchange for a cash payment of $26.00 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes restricted stock units ("RSUs") that represent the Reporting Person's right to receive shares of Class A common stock of the Issuer. The RSUs were cancelled pursuant to that certain Merger Agreement, dated November 5, 2021, between the Issuer, Condor BidCo, Inc. and Condor Merger Sub, Inc., in exchange for a cash payment of $26.00 per share.
Science 37 Holdings, Inc.
Report date March 12, 2024 · Filed March 12, 2024
Section 16 reporting ended · disclosed 2024-03-12. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-03-12 transaction · row 1
1 source rowRow 1 · 2024-03-12 · Other · Disposed 2,050 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of January 28, 2024, among the Issuer, eMed, LLC, a Delaware limited liability company ("Parent"), and Marlin Merger Sub Corporation, a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer ("Issuer Common Stock") at a purchase price of $5.75 per share, without interest and subject to applicable withholding taxes (the "Offer Price"). After completion of the tender offer, Merger Sub merged with and into the Issuer, effective as of March 12, 2024 (such date and time of such merger, the "Effective Time"). These shares of Issuer Common Stock were tendered for purchase pursuant to the tender offer. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-03-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-03-12 · Disposition to issuer · Disposed 24,742 · Balance 0 F2: Represents restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represented a contingent right to receive one share of Issuer Common Stock upon vesting of the RSU. F3: Pursuant to the Merger Agreement, at the Effective Time, each RSU that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive a cash payment (without interest and subject to any applicable tax withholding) equal to (A) the Offer Price, multiplied by (B) the number of shares of Issuer Common Stock subject to such RSU. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $201.00 | Direct | 0 |
Reported balance
After 2024-03-12 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-03-12 · Disposition to issuer · Disposed 1,378 · Balance 0 F4: Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Issuer Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of January 28, 2024, among the Issuer, eMed, LLC, a Delaware limited liability company ("Parent"), and Marlin Merger Sub Corporation, a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer ("Issuer Common Stock") at a purchase price of $5.75 per share, without interest and subject to applicable withholding taxes (the "Offer Price"). After completion of the tender offer, Merger Sub merged with and into the Issuer, effective as of March 12, 2024 (such date and time of such merger, the "Effective Time"). These shares of Issuer Common Stock were tendered for purchase pursuant to the tender offer.
F2: Represents restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represented a contingent right to receive one share of Issuer Common Stock upon vesting of the RSU.
F3: Pursuant to the Merger Agreement, at the Effective Time, each RSU that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive a cash payment (without interest and subject to any applicable tax withholding) equal to (A) the Offer Price, multiplied by (B) the number of shares of Issuer Common Stock subject to such RSU.
F4: Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Issuer Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2023 Filed Dec 5, 2023 21:07 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionClass A Common Stock | 1,000 | $12.32 | $12,320.00 |
DisclosureSEC source: 0001562180-23-008100 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,770 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 90 days prior to the trading date. Read SEC document |
| May 11, 2023 Filed May 12, 2023 16:21 UTC | Science 37 Holdings, Inc. SNCE · Entity 15235 | GrantRestricted Stock Units · Derivative | 494,853 | $0.00 | $0.00 |
DisclosureSEC source: 0001819113-23-000044 · wf-form4_168392289213317.xml · derivative · entry 3 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 494,853 Underlying: Common Stock · 494,853 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Science 37 Holdings, Inc.'s common stock. F4 · derivative.exercise_date: On May 11, 2023, Ms. Rollins received restricted stock units representing 494,853 shares, vesting in full on the earlier of the one-year anniversary of the grant date and the date of the Company's next annual stockholder meeting following the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date. F4 · derivative.expiration_date: On May 11, 2023, Ms. Rollins received restricted stock units representing 494,853 shares, vesting in full on the earlier of the one-year anniversary of the grant date and the date of the Company's next annual stockholder meeting following the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date. Read SEC document |
| May 11, 2023 Filed May 12, 2023 16:21 UTC | Science 37 Holdings, Inc. SNCE · Entity 15235 | Exercise / conversionRestricted Stock Units · Derivative | 40,983 | $0.00 | $0.00 |
DisclosureSEC source: 0001819113-23-000044 · wf-form4_168392289213317.xml · derivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,983 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Science 37 Holdings, Inc.'s common stock. F3 · derivative.exercise_date: On May 23, 2022, Ms.Rollins received restricted stock units representing 40,983 shares, vesting in full on the earlier of the one-year anniversary of the grant date and the date of the Company's next annual stockholder meeting following the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date. F3 · derivative.expiration_date: On May 23, 2022, Ms.Rollins received restricted stock units representing 40,983 shares, vesting in full on the earlier of the one-year anniversary of the grant date and the date of the Company's next annual stockholder meeting following the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date. Read SEC document |
| May 11, 2023 Filed May 12, 2023 16:21 UTC | Science 37 Holdings, Inc. SNCE · Entity 15235 | Exercise / conversionCommon Stock | 40,983 | $0.00 | $0.00 |
DisclosureSEC source: 0001819113-23-000044 · wf-form4_168392289213317.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Acquisition of common stock resulting from vesting of the restricted stock units granted to Ms. Rollins on May 23, 2022. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:50 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,000 | $84.70 | $84,700.00 |
DisclosureSEC source: 0001209191-23-028504 · doc4.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,541 F1 · balance_after: Shares held following the reported transaction include 3,296 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| March 21, 2023 Filed Mar 23, 2023 22:19 UTC | Xometry, Inc. XMTR · Entity 1915 | GrantClass A Common Stock | 7,041 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-003091 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,770 F1 · shares: Represents a restricted stock unit ("RSU") grant. All of the shares underlying the RSUs will vest on January 1, 2024, subject to the Reporting Person's continuous service. F2 · price: Each RSU represents a contingent right to receive one share of the Class A Common Stock of the Issuer. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,000 | $82.04 | $82,040.00 |
DisclosureSEC source: 0001209191-23-015771 · doc4.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,541 F1 · balance_after: Shares held following the reported transactions include 3,296 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 07, 2023 Filed Feb 10, 2023 02:32 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 3,296 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-008215 · doc4.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,541 F1 · acquired: Award represents a total of 3,296 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2024 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. F2 · balance_after: Shares held following the reported transactions include 3,296 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 22:08 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $12.32 | $0.00 |
DisclosureSEC source: 0001562180-23-000141 · primarydocument.xml · derivative · entry 3 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 30 days prior to the trading date. F3 · derivative.exercise_date: Shares vest in 48 monthly installments beginning on April 2, 2021, subject to the Reporting Person's continuous service. Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 22:08 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 2,000 | $32.32 | $64,640.00 |
DisclosureSEC source: 0001562180-23-000141 · primarydocument.xml · nonDerivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,729 F2 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 30 days prior to the trading date. Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 22:08 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionClass A Common Stock | 2,000 | $12.32 | $24,640.00 |
DisclosureSEC source: 0001562180-23-000141 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 30 days prior to the trading date. Read SEC document |
| November 25, 2022 Filed Nov 28, 2022 22:02 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $12.32 | $0.00 |
DisclosureSEC source: 0001562180-22-007909 · primarydocument.xml · derivative · entry 4 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 30 days prior to the trading date. F4 · derivative.exercise_date: Shares vest in 48 monthly installments beginning on April 2, 2021, subject to the Reporting Person's continuous service. Read SEC document |
| November 25, 2022 Filed Nov 28, 2022 22:02 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 141 | $42.85 | $6,041.85 |
DisclosureSEC source: 0001562180-22-007909 · primarydocument.xml · nonDerivative · entry 3 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,729 F2 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 30 days prior to the trading date. Read SEC document |
| November 25, 2022 Filed Nov 28, 2022 22:02 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 1,859 | $42.36 | $78,749.10 |
DisclosureSEC source: 0001562180-22-007909 · primarydocument.xml · nonDerivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,870 F2 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 30 days prior to the trading date. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.76 to $42.74, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the range. Read SEC document |
| November 25, 2022 Filed Nov 28, 2022 22:02 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionClass A Common Stock | 2,000 | $12.32 | $24,640.00 |
DisclosureSEC source: 0001562180-22-007909 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 30 days prior to the trading date. Read SEC document |
| October 25, 2022 Filed Oct 26, 2022 22:27 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $12.32 | $0.00 |
DisclosureSEC source: 0001562180-22-007337 · primarydocument.xml · derivative · entry 4 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 30 days prior to the trading date. F5 · derivative.exercise_date: Shares vest in 48 monthly installments beginning on April 2, 2021, subject to the Reporting Person's continuous service. Read SEC document |
| October 25, 2022 Filed Oct 26, 2022 22:27 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 1,755 | $59.43 | $104,304.74 |
DisclosureSEC source: 0001562180-22-007337 · primarydocument.xml · nonDerivative · entry 3 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,729 F2 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 30 days prior to the trading date. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.975 to $59.78, inclusive. Read SEC document |
| October 25, 2022 Filed Oct 26, 2022 22:27 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 245 | $58.40 | $14,307.07 |
DisclosureSEC source: 0001562180-22-007337 · primarydocument.xml · nonDerivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,484 F2 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 30 days prior to the trading date. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.76 to $58.63, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the ranges set forth in footnotes (3) and (4) to this Form 4. Read SEC document |
| October 25, 2022 Filed Oct 26, 2022 22:27 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionClass A Common Stock | 2,000 | $12.32 | $24,640.00 |
DisclosureSEC source: 0001562180-22-007337 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 30 days prior to the trading date. Read SEC document |
| September 26, 2022 Filed Sep 27, 2022 20:48 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $12.32 | $0.00 |
DisclosureSEC source: 0001562180-22-006849 · primarydocument.xml · derivative · entry 5 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 30 days prior to the trading date. F6 · derivative.exercise_date: Shares vest in 48 monthly installments beginning on April 2, 2021, subject to the Reporting Person's continuous service. Read SEC document |
| September 26, 2022 Filed Sep 27, 2022 20:48 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 130 | $60.59 | $7,877.03 |
DisclosureSEC source: 0001562180-22-006849 · primarydocument.xml · nonDerivative · entry 4 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,729 F2 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 30 days prior to the trading date. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.59 to $60.595, inclusive. Read SEC document |
| September 26, 2022 Filed Sep 27, 2022 20:48 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 722 | $59.78 | $43,158.85 |
DisclosureSEC source: 0001562180-22-006849 · primarydocument.xml · nonDerivative · entry 3 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,859 F2 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 30 days prior to the trading date. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.47 to $60.44, inclusive. Read SEC document |
| September 26, 2022 Filed Sep 27, 2022 20:48 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 1,148 | $58.93 | $67,650.95 |
DisclosureSEC source: 0001562180-22-006849 · primarydocument.xml · nonDerivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,581 F2 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 30 days prior to the trading date. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.47 to $59.42, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the ranges set forth in footnotes (3), (4) and (5) to this Form 4. Read SEC document |
| September 26, 2022 Filed Sep 27, 2022 20:48 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionClass A Common Stock | 2,000 | $12.32 | $24,640.00 |
DisclosureSEC source: 0001562180-22-006849 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 30 days prior to the trading date. Read SEC document |
| August 26, 2022 Filed Aug 30, 2022 20:18 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $12.32 | $0.00 |
DisclosureSEC source: 0001562180-22-006370 · primarydocument.xml · derivative · entry 4 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Class A Common Stock · 2,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date and amended at least 14 days prior to the trading date. F5 · derivative.exercise_date: Shares vest in 48 monthly installments beginning on April 2, 2021, subject to the Reporting Person's continuous service. Read SEC document |
| August 26, 2022 Filed Aug 30, 2022 20:18 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 223 | $47.18 | $10,520.81 |
DisclosureSEC source: 0001562180-22-006370 · primarydocument.xml · nonDerivative · entry 3 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,729 F2 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date and amended at least 14 days prior to the trading date. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.87 to $47.61, inclusive. Read SEC document |
| August 26, 2022 Filed Aug 30, 2022 20:18 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 1,777 | $46.03 | $81,787.67 |
DisclosureSEC source: 0001562180-22-006370 · primarydocument.xml · nonDerivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,952 F2 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date and amended at least 14 days prior to the trading date. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.73 to $46.65, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the ranges set forth in footnotes (3) and (4) to this Form 4. Read SEC document |
| August 26, 2022 Filed Aug 30, 2022 20:18 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionClass A Common Stock | 2,000 | $12.32 | $24,640.00 |
DisclosureSEC source: 0001562180-22-006370 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date and amended at least 14 days prior to the trading date. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:53 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,000 | $80.00 | $80,000.00 |
DisclosureSEC source: 0001209191-22-045628 · doc4.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,245 F1 · balance_after: Shares held following the reported transactions include 2,783 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:20 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $12.32 | $0.00 |
DisclosureSEC source: 0001562180-22-006071 · primarydocument.xml · derivative · entry 3 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 10,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Shares vest in 48 monthly installments beginning on April 2, 2021, subject to the Reporting Person's continuous service. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:20 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 10,000 | $50.00 | $500,000.00 |
DisclosureSEC source: 0001562180-22-006071 · primarydocument.xml · nonDerivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,729 F2 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:20 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionClass A Common Stock | 10,000 | $12.32 | $123,200.00 |
DisclosureSEC source: 0001562180-22-006071 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date. Read SEC document |
| May 23, 2022 Filed May 24, 2022 16:23 UTC | Science 37 Holdings, Inc. SNCE · Entity 15235 | GrantRestricted Stock Units · Derivative | 40,983 | $0.00 | $0.00 |
DisclosureSEC source: 0001819113-22-000044 · wf-form4_165342381504356.xml · derivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,983 Underlying: Common Stock · 40,983 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Science 37 Holdings, Inc.'s common stock. F2 · derivative.exercise_date: On May 23, 2022, Ms. Rollins received restricted stock units representing 40,983 shares, vesting in full on the earlier of the one-year anniversary of the grant date and the date of the Company's next annual stockholder meeting following the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date. F2 · derivative.expiration_date: On May 23, 2022, Ms. Rollins received restricted stock units representing 40,983 shares, vesting in full on the earlier of the one-year anniversary of the grant date and the date of the Company's next annual stockholder meeting following the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date. Read SEC document |
| March 15, 2022 Filed Mar 18, 2022 00:30 UTC | Xometry, Inc. XMTR · Entity 1915 | GrantClass A Common Stock | 3,729 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002775 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,729 F1 · shares: Represents a restricted stock unit ("RSU") grant. All of the shares underlying the RSUs will vest on January 1, 2023, subject to the Reporting Person's continuous service. F2 · price: Each RSU represents a contingent right to receive one share of the Class A Common Stock of the Issuer. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:21 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $12.32 | $0.00 |
DisclosureSEC source: 0001562180-22-002109 · primarydocument.xml · derivative · entry 3 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Shares vest in 48 monthly installments beginning on April 2, 2021, subject to the Reporting Person's continuous service. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:21 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 2,000 | $50.00 | $100,000.00 |
DisclosureSEC source: 0001562180-22-002109 · primarydocument.xml · nonDerivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:21 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionClass A Common Stock | 2,000 | $12.32 | $24,640.00 |
DisclosureSEC source: 0001562180-22-002109 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 17:30 UTC | McAfee Corp. MCFE · Entity 11636 | Disposition to issuerClass A Common Stock | 6,878 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-009138 · doc4.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Includes restricted stock units ("RSUs") that represent the Reporting Person's right to receive shares of Class A common stock of the Issuer. The RSUs were cancelled pursuant to that certain Merger Agreement, dated November 5, 2021, between the Issuer, Condor BidCo, Inc. and Condor Merger Sub, Inc., in exchange for a cash payment of $26.00 per share. F1 · price: Includes restricted stock units ("RSUs") that represent the Reporting Person's right to receive shares of Class A common stock of the Issuer. The RSUs were cancelled pursuant to that certain Merger Agreement, dated November 5, 2021, between the Issuer, Condor BidCo, Inc. and Condor Merger Sub, Inc., in exchange for a cash payment of $26.00 per share. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 01:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 2,783 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-008257 · doc4.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,245 F1 · acquired: Award represents a total of 2,783 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2023 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. F2 · balance_after: Shares held following the reported transactions include 2,783 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| October 07, 2021 Filed Oct 12, 2021 21:59 UTC | Science 37 Holdings, Inc. SNCE · Entity 15235 | GrantStock Option · Derivative | 27,575 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0001104659-21-125571 · tm2129868-8_4seq1.xml · derivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,575 Underlying: Common Stock · 27,575 shares Expires 2031-10-07 F1 · derivative.exercise_date: The Stock Option shall vest and become exercisable in a single installment on the earlier of October 7, 2022 and the first annual meeting of the Company's stockholders to occur after the date of grant, subject to the grantee's cotinued service as a director thorugh the applicable vesting date. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 17:05 UTC | McAfee Corp. MCFE · Entity 11636 | GrantClass A Common Stock | 6,878 | $21.60 | $148,564.80 |
DisclosureSEC source: 0000899243-21-039589 · doc4.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,878 Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 23:08 UTC | Xometry, Inc. XMTR · Entity 1915 | OtherStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $12.32 | $0.00 |
DisclosureSEC source: 0001209191-21-045918 · doc4.xml · derivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Class A Common Stock · 70,000 shares Expires 2031-02-24 F1 · derivative.exercise_date: Vests in 48 equal monthly installments, commencing on March 2, 2021, subject to the Reporting Person's continuous service. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 23:08 UTC | Xometry, Inc. XMTR · Entity 1915 | OtherStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $12.32 | $0.00 |
DisclosureSEC source: 0001209191-21-045918 · doc4.xml · derivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 70,000 shares Expires 2031-02-24 F1 · derivative.exercise_date: Vests in 48 equal monthly installments, commencing on March 2, 2021, subject to the Reporting Person's continuous service. F2 · derivative.underlying: Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class A Common Stock in an exempt transaction pursuant to Rule 16b-7. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 23:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 2,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-014996 · doc4.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,462 F1 · acquired: Award represents a total of 2,462 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2022 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. F2 · balance_after: Shares held following the reported transactions include 2,462 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.